Human bone marrow mast cells from indolent systemic mast cell disease constitutively express increased amounts of the CD63 protein on their surface

Communications in Clinical Cytometry

Volumn 34, Issue 5, 1998, Pages 223-228

  Escribano, Luis ^a   Orfao, Alberto ^b,d   Díaz Agustín, Beatriz ^a   Cerveró, Carlos ^a   Herrero, Sonia ^a   Villarrubia, Jesús ^a   Bravo, Pilar ^a   Torrelo, Antonio ^c   Montero, Teresa ^a   Valdemoro, Mercedes ^c   Velasco, José Luis ^a   Navarro, José Luis ^a   San Miguel, Jesús F ^b  

^a UNIVERSITY OF ALCALÁ   (Spain)

^b UNIVERSITY OF SALAMANCA   (Spain)

^c HOSPITAL INFANTIL UNIVERSITARIO NIÑO JESÚS   (Spain)

^d HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

Author keywords

CD63 molecule; Flow cytometry; Human; Mast cells

Indexed keywords

CD63 ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MAST CELL; MASTOCYTOSIS; MONOCLONAL IMMUNOGLOBULINEMIA; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; ANTIGENS, CD; BIOLOGICAL MARKERS; BONE MARROW CELLS; CHILD; HUMANS; LYMPHOMA, B-CELL; MAST CELLS; MASTOCYTOSIS; PLATELET MEMBRANE GLYCOPROTEINS; SURFACE PROPERTIES;

EID: 0542420329     PISSN: 01964763     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0320(19981015)34:5<223::AID-CYTO3>3.0.CO;2-B     Document Type: Article

References (35)

1. Horejsi V, Vlcek C: Novel structurally distinct family of leucocyte surface glycoproteins including CD9, CD37, CD53 and CD63. FEBS Lett 288:1-4, 1991
2. Nieuwenhuis HK, van Oosterhout JJ, Rozemuller E, van Iwaarden F, Sixma JJ: Studies with a monoclonal antibody against activated platelets: Evidence that a secreted 53,000-molecular weight lysosome-like granule protein is exposed on the surface of activated platelets in the circulation. Blood 70:838-845, 1987.
3. Fukuroi T, Kawakatsu T, Nomura S, Hamamoto K, Kido H, Yamaguchi K, Suzuki M, Yanabu M, Soga T, Kokawa T, Yasunaga K: Characterization of a novel activation-specific antiplatelet monoclonal antibody. Haemostasis 23:112-120, 1993
4. Hamamoto K, Ohga S, Nomura S, Yasunaga K: Cellular distribution of CD63 antigen in platelets and in three megakaryocytic cell lines. Histochem J 26:367-375, 1994
5. Metzelar MJ, Korteweg J, Sixma JJ, Nieuwenhuis HK: Comparison of platelet membrane markers for the detection of platelet activation in vitro and during platelet storage and cardiopulmonary bypass surgery. J Lab Clin Med 121:579-587, 1993.
6. Berditchevski F, Bazzoni G, Hemler ME: Specific association of CD63 with the VLA-3 and VLA-6 integrins. J Biol Chem 270:17784-17790, 1995.
7. 1 (CD49d/CD29). J Immunol 157:2039-2047, 1996.
8. Knol EF, Mul FPJ, Jansen H, Calafat J, Roos D: Monitoring human basophil activation via CD63 monoclonal antibody. J Allergy Clin Immunol 88:328-338, 1991.
9. Cham BP, Gerrard JM, Bainton DF: Granulophysin is located in the membrane of azurophilic granules in human neutrophils and mobilizes to the plasma membrane following cell stimulation. Am J Pathol 144:1369-1380, 1994.
10. Kuijpers TW, Tool AT, Van der School CE, Ginsel LA, Onderwater JJ, Roos D, Verhoeven AJ: Membrane surface antigen expression on neutrophils: a reappraisal of the use of surface markers for neutrophil activation. Blood 78:1105-1111, 1991.
11. Mengelers HJ, Maikoe T, Brinkman L, Hooibrink B, Lammers JW, Koenderman L: Immunophenotyping of eosinophils recovered from blood and BAL of allergic asthmatics. Am J Respir Crit Care Med 149:345-351, 1994.
12. Peters PJ, Borst J, Oorschot V, Fukuda M, Krahenbuhl O, Tschopp J, Slot JW, Geuze HJ: Cytotoxic T lymphocyte granules are secretory lysosomes. containing both perform and granzymes. J Exp Med 173:1099-1109, 1991.
13. Vischer UM, Wagner DD: CD63 is a component of Weibel-Palade bodies of human endothelial cells. Blood 82:1184-1191, 1993.
14. Valent P, Bettelheim P: Cell surface structures on human basophils and mast cells: Biochemical and functional characterization. Adv Immunol 52:333-423, 1992.
15. Agis H, Fureder W, Bankl HC, Kundi M, Sperr WR, Willheim M, Boltz-Nitulescu G, Butterfield JH, Kishi K, Lechner K, Valent P: Comparative immunophenotypic analysis of human mast cells, blood basophils and monocytcs. Immunology 87:535-543, 1996.
16. Füreder W, Bankl HC, Toth J, Walchshofer S, Sperr W, Agis H, Semper H, Sillaber C, Lechner K, Valent P: Immunophenotypic and functional characterization of human tonsillar mast cells. J Leuk Biol 61:592-599, 1997.
17. Nishikata H, Oliver C, Mergenhagen SE, Siraganian RP: The rat mast cell antigen AD1 (homologue to human CD63 or melanoma antigen ME491) is expressed in other cells in culture. J Immunol 149:862-870, 1992.
18. Furuno T, Teshima R, Kitani S, Sawada J, Nakanishi M: Surface expression of CD63 antigen (AD1 antigen) in P815 mastocytoma cells by transfected IgE receptors. Biochem Biophys Res Commun 219:740-744, 1996.
19. Travis WD, Li CY, Bergstralh EJ, Yam LT, Swee RG: Systemic mast cell disease. Analysis of 58 cases and literature review. Medicine 67:345-368, 1988.
20. Horan RF, Austen KF: Systemic mastocytosis: retrospective review of a decade's clinical experience at the Brigham and Women's Hospital. J Invest Dermatol 96:5S-13S, 1991.
21. Metcalfe DD: Clinical advances in mastocytosis: an interdisciplinary roundtable discussion. J Invest Dermatol [Suppl] 96:1S-65S, 1991
22. Roberts LJ II. Gates JA: Biochemical diagnosis of systemic mast cell disorders. J Invest Dermatol 96:19S-25S, 1991.
23. Gruchalla RS: Southwestern Internal Medicine Conference. Mastocytosis: Developments during the past decade. Am J Med Sci 309:328-338, 1995.
24. Escribano L, Orfao A, Díaz Agustin B, Villarrubia J, Cerveró C, López A, García Marcos A, Bellas C, Fernández Cañadas S, Cuevas M, Sanchez A, Velasco JL, Navarro JL, San Miguel JF: Indolent systemic mast cell disease in adults Immunophenotypic characterization and its diagnostic implications. Blood 91:2731-2736, 1997.
25. Azana JM, Torrelo A, Mediero IG, Zambrano A: Urticaria pigmentosa: a review of 67 pediatric cases. Pediatr Dermatol 11:102-106, 1994.
26. Orfao A, Escribano L, Villarrubia J, Velasco JL, Cerveró C, Ciudad J, Navarro JL, San Miguel JF: Flow cytometric analysis of mast cells from normal and pathological human bone marrow samples. Identification and enumeration. Am J Pathol 149:1493-1499, 1996.
27. Kitani S, Berenstein E, Mergenhagen S, Tempst P, Siraganian RP: A cell surface glycoprotein of rat basophilic leukemia cells close to the high affinity IgE receptor (FceRI). Similarity to human melanoma differentiation antigen ME491. J Biol Chem 266:1903-1909, 1991.
28. Takagi M, Nakahata T, Koike K, Kobayashi T, Tsuji K, Kojima S, Hirano T, Miyajima A, Arai K-I, Akabane T Stimulation of connective tissue-type mast cell proliferation by crosslinking of cell-bound IgE. J Exp Med 170:233-244, 1989.
29. Wright MD, Tomlinson MG: The ins and outs of the transmembrane 4 superfamily. Immunol Today 15:588-594, 1994.
30. Metezelaar MJ, Wijngaard PLJ, Peters PJ, Sixma JJ, Nieuwenhuis HK, Clevers HC: CD63 antigen A novel lysosomal membrane glycoprotein. cloned by a screening procedure for intracellular antigens in eukaryotic cells. J Biol Chem 266:3239-3245, 1991.
31. Behr S, Schriever F: Engaging CD19 or target of an antiproliferative antibody 1 on human B lymphocytes induces binding of B cells to the interfollicular stroma of human tonsils via integrin alpha 4/beta 1 and fibronectin. J Exp Med 182:1191-1199, 1995
32. Miyake M, Koyama M, Seno M, Ikeyama S: Identification of the motility-related protein (MRP-1), recognized by monoclonal antibody M31-15, which inhibits cell motility. J Exp Med 174:1347-1354, 1991
33. Ikeyama S, Koyama M, Yamaoko M, Sasada R, Miyake M: Suppression of cell motility and metastasis by transfection with human motility-related protein (MRP-1/CD9) DNA. J Exp Med 177:1231-1237, 1993
34. Anton ES, Hadjiargyrou M, Patterson PH, Matthew WD: CD9 plays a role in Schwann cell migration in vitro. J Neurosci 15:584-595, 1995.
35. Hotta H, Ross AH, Huebner K, Isobe M, Wendeborn S, Chao MV, Ricciardi RP, Tsujimoto Y, Croce CM, Koprowski H: Molecular cloning and characterization of an antigen associated with early stages of melanoma tumor progression. Cancer Res 48:2955-2962, 1988.